Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
2
×
neuroscience
2
×
bial
boston
boston blog main
boston top stories
brexanalone
clinical data
clinical trials
depression
drug development
fda
jeff jonas
major depressive disorder
mental illness
national top stories
neurocrine
neurodegeneration
opicapone
parkinson's disease
phase 3 trial
postpartum depression
psychiatric disorders
sage therapeutics
san diego
san diego blog main
san diego top stories
What
fda
2
×
add
approval
brexanalone
called
carbidopa
combination
control
daily
depression
disease
drug
experience
gets
hits
hour
infusion
levodopa
mark
medical
medication
neurocrine
nod
parkinson’s
patients
phase
pill
postpartum
ppd
sage
soon
stock
supervised
surges
symptoms
therapeutics
time
trial
win
Language
unset
Current search:
neuroscience
×
fda
×
" national blog main "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
